Difference between revisions of "Cardiovascular Risks in Patients with COVID-19: Potential Mechanisms and Areas of Uncertainty (DOI: 10.1007/s11886-020-01293-2) (Q10321)"

Latest revision as of 15:53, 23 June 2020

Research article published in Curr Cardiol Rep; 2020 04 29 ; 22 (5) 34

Language	Label	Description	Also known as
English	Cardiovascular Risks in Patients with COVID-19: Potential Mechanisms and Areas of Uncertainty (DOI: 10.1007/s11886-020-01293-2)	Research article published in Curr Cardiol Rep; 2020 04 29 ; 22 (5) 34

Statements

instance of

Scientific publication

0 references

Research article

0 references

Issue

5

1 reference

data source

Pubtator Central BioC-JSON formatted article files

Publication Date

29 April 2020

1 reference

data source

Pubtator Central BioC-JSON formatted article files

Volume

22

1 reference

data source

Pubtator Central BioC-JSON formatted article files

DOI Identifier

10.1007/s11886-020-01293-2

1 reference

data source

Pubtator Central BioC-JSON formatted article files

PubMed ID

32350632

1 reference

data source

Pubtator Central BioC-JSON formatted article files

PMC Identifier

PMC7189178

1 reference

data source

Pubtator Central BioC-JSON formatted article files

Published In Name String

Curr Cardiol Rep

1 reference

data source

Pubtator Central BioC-JSON formatted article files

Author Keyword

COVID-19

1 reference

data source

Pubtator Central BioC-JSON formatted article files

ACE2

1 reference

data source

Pubtator Central BioC-JSON formatted article files

Cardiovascular risk factors

1 reference

data source

Pubtator Central BioC-JSON formatted article files

Mortality

1 reference

data source

Pubtator Central BioC-JSON formatted article files

Myocardial injury

1 reference

data source

Pubtator Central BioC-JSON formatted article files

Arrhythmia

1 reference

data source

Pubtator Central BioC-JSON formatted article files

Full Citation Data string

Curr Cardiol Rep; 2020 04 29 ; 22 (5) 34.

1 reference

data source

Pubtator Central BioC-JSON formatted article files

title

Cardiovascular Risks in Patients with COVID-19: Potential Mechanisms and Areas of Uncertainty (English)

1 reference

data source

Pubtator Central BioC-JSON formatted article files

Collection or Dataset of Origin

Pubtator Central BioC-JSON formatted article files

0 references

Author

Cheng P (1st author of DOI: 10.1007/s11886-020-01293-2)

1 reference

Series Ordinal

1

Zhu H (2nd author of DOI: 10.1007/s11886-020-01293-2)

1 reference

Series Ordinal

2

Witteles RM (3rd author of DOI: 10.1007/s11886-020-01293-2)

1 reference

Series Ordinal

3

Wu JC (4th author of DOI: 10.1007/s11886-020-01293-2)

1 reference

Series Ordinal

4

Quertermous T (5th author of DOI: 10.1007/s11886-020-01293-2)

1 reference

Series Ordinal

5

Wu SM (6th author of DOI: 10.1007/s11886-020-01293-2)

1 reference

Series Ordinal

6

Rhee JW (7th author of DOI: 10.1007/s11886-020-01293-2)

1 reference

Series Ordinal

7

Cites Publication

Huang C, et al, Lancet (2020), cited as Ref 1 in DOI: 10.1007/s11886-020-01293-2

0 references

CDC, et al, (Accessed March 31, 2020), cited as Ref 2 in DOI: 10.1007/s11886-020-01293-2

0 references

Johns Hopkins Coronavirus Resource Center, et al, (Accessed March 31, 2020), cited as Ref 3 in DOI: 10.1007/s11886-020-01293-2

0 references

Wu Z, et al, JAMA (2020), cited as Ref 4 in DOI: 10.1007/s11886-020-01293-2

0 references

Onder G, et al, JAMA (2020), cited as Ref 5 in DOI: 10.1007/s11886-020-01293-2

0 references

Zhou F, et al, Lancet (2020), cited as Ref 6 in DOI: 10.1007/s11886-020-01293-2

0 references

Ruan Q, et al, Intensive Care Med (2020), cited as Ref 7 in DOI: 10.1007/s11886-020-01293-2

0 references

Wang D, et al, JAMA (2020), cited as Ref 8 in DOI: 10.1007/s11886-020-01293-2

0 references

Zhou P, et al, Nature (2020), cited as Ref 9 in DOI: 10.1007/s11886-020-01293-2

0 references

Kuba K, et al, Nat Med (2005), cited as Ref 10 in DOI: 10.1007/s11886-020-01293-2

0 references

Matsuyama S, et al, J Virol (2010), cited as Ref 11 in DOI: 10.1007/s11886-020-01293-2

0 references

Wrapp D, et al, Science (2020), cited as Ref 12 in DOI: 10.1007/s11886-020-01293-2

0 references

Hoffmann M, et al, Cell (2020), cited as Ref 13 in DOI: 10.1007/s11886-020-01293-2

0 references

Zhao Y, et al, BioRxiv (2020), cited as Ref 14 in DOI: 10.1007/s11886-020-01293-2

0 references

Sungnak W, et al, arXiv (2020), cited as Ref 15 in DOI: 10.1007/s11886-020-01293-2

0 references

Brann D, et al, BioRxiv (2020), cited as Ref 16 in DOI: 10.1007/s11886-020-01293-2

0 references

The Human Protein Atlas , et al, (Accessed April 1, 2020), cited as Ref 17 in DOI: 10.1007/s11886-020-01293-2

0 references

Leung WK, et al, Gastroenterology (2003), cited as Ref 18 in DOI: 10.1007/s11886-020-01293-2

0 references

Xu Y, et al, Nat Med (2020), cited as Ref 19 in DOI: 10.1007/s11886-020-01293-2

0 references

Ferrario CM, et al, Circulation (2005), cited as Ref 20 in DOI: 10.1007/s11886-020-01293-2

0 references

Imai Y, et al, Nature (2005), cited as Ref 21 in DOI: 10.1007/s11886-020-01293-2

0 references

Li Y, et al, Sci Rep (2016), cited as Ref 22 in DOI: 10.1007/s11886-020-01293-2

0 references

HFSA/ACC/AHA, et al, (Accessed April 1, 2020), cited as Ref 23 in DOI: 10.1007/s11886-020-01293-2

0 references

Wu C, et al, JAMA Intern Med (2020), cited as Ref 24 in DOI: 10.1007/s11886-020-01293-2

0 references

Arentz M, et al, JAMA (2020), cited as Ref 25 in DOI: 10.1007/s11886-020-01293-2

0 references

Guan W-J, et al, N Engl J Med (2020), cited as Ref 26 in DOI: 10.1007/s11886-020-01293-2

0 references

Liu J, et al, JAMA (2004), cited as Ref 27 in DOI: 10.1007/s11886-020-01293-2

0 references

Shi S, et al, JAMA Cardiol (2020), cited as Ref 28 in DOI: 10.1007/s11886-020-01293-2

0 references

Hu H, et al, Eur Heart J (2020), cited as Ref 29 in DOI: 10.1007/s11886-020-01293-2

0 references

Kwong JC, et al, N Engl J Med (2018), cited as Ref 30 in DOI: 10.1007/s11886-020-01293-2

0 references

Harris JE, et al, Int J Cardiol Heart Vasc (2019), cited as Ref 31 in DOI: 10.1007/s11886-020-01293-2

0 references

Ludwig A, et al, BMC Cardiovasc Disord (2015), cited as Ref 32 in DOI: 10.1007/s11886-020-01293-2

0 references

Grasselli G, et al, JAMA (2020), cited as Ref 33 in DOI: 10.1007/s11886-020-01293-2

0 references

Walkey AJ, et al, Chest (2014), cited as Ref 34 in DOI: 10.1007/s11886-020-01293-2

0 references

Traebert M, et al, Eur J Pharmacol (2004), cited as Ref 35 in DOI: 10.1007/s11886-020-01293-2

0 references

has part

Section 1: Introduction (from DOI: 10.1007/s11886-020-01293-2)

0 references

Section 2: SARS-CoV-2 Biology and Clinical Implications (from DOI: 10.1007/s11886-020-01293-2)

0 references

Section 3: Cardiovascular Comorbidities and COVID-19 Outcomes (from DOI: 10.1007/s11886-020-01293-2)

0 references

Section 3.1: Cardiac Complications of COVID-19 (from DOI: 10.1007/s11886-020-01293-2)

0 references

Section 3.1.1: Myocardial Injury and Heart Failure (from DOI: 10.1007/s11886-020-01293-2)

0 references

Section 3.1.2: Arrhythmia (from DOI: 10.1007/s11886-020-01293-2)

0 references

Section 4: Conclusion (from DOI: 10.1007/s11886-020-01293-2)

0 references

Conflict of Interest (from DOI: 10.1007/s11886-020-01293-2)

0 references

References (from DOI: 10.1007/s11886-020-01293-2)

0 references

Sitelinks

⧼wikibase-sitelinks-sliswiki⧽(1 entry)

sliswiki Cardiovascular Risks in Patients with COVID-19: Potential Mechanisms and Areas of Uncertainty (DOI: 10.1007/s11886-020-01293-2)

@@ Property / Full Citation Data string / Property / Full Citation Data string @@
-Curr Cardiol Rep; 2020 04 29 ; 22 (5) 34. doi:10.1007/s11886-020-01293-2
+Curr Cardiol Rep; 2020 04 29 ; 22 (5) 34.
@@ Property / Cites Publication @@
+Li Y, et al, Sci Rep (2016), cited as Ref 22 in DOI: 10.1007/s11886-020-01293-2
+Normal rank
@@ Property / Cites Publication @@
+HFSA/ACC/AHA, et al,  (Accessed April 1, 2020), cited as Ref 23 in DOI: 10.1007/s11886-020-01293-2
+Normal rank
@@ Property / Cites Publication @@
+Wu C, et al, JAMA Intern Med (2020), cited as Ref 24 in DOI: 10.1007/s11886-020-01293-2
+Normal rank
@@ Property / Cites Publication @@
+Arentz M, et al, JAMA (2020), cited as Ref 25 in DOI: 10.1007/s11886-020-01293-2
+Normal rank
@@ Property / Cites Publication @@
+Guan W-J, et al, N Engl J Med (2020), cited as Ref 26 in DOI: 10.1007/s11886-020-01293-2
+Normal rank
@@ Property / Cites Publication @@
+Liu J, et al, JAMA (2004), cited as Ref 27 in DOI: 10.1007/s11886-020-01293-2
+Normal rank
@@ Property / Cites Publication @@
+Shi S, et al, JAMA Cardiol (2020), cited as Ref 28 in DOI: 10.1007/s11886-020-01293-2
+Normal rank
@@ Property / Cites Publication @@
+Hu H, et al, Eur Heart J (2020), cited as Ref 29 in DOI: 10.1007/s11886-020-01293-2
+Normal rank
@@ Property / Cites Publication @@
+Kwong JC, et al, N Engl J Med (2018), cited as Ref 30 in DOI: 10.1007/s11886-020-01293-2
+Normal rank
@@ Property / Cites Publication @@
+Harris JE, et al, Int J Cardiol Heart Vasc (2019), cited as Ref 31 in DOI: 10.1007/s11886-020-01293-2
+Normal rank
@@ Property / Cites Publication @@
+Ludwig A, et al, BMC Cardiovasc Disord (2015), cited as Ref 32 in DOI: 10.1007/s11886-020-01293-2
+Normal rank
@@ Property / Cites Publication @@
+Grasselli G, et al, JAMA (2020), cited as Ref 33 in DOI: 10.1007/s11886-020-01293-2
+Normal rank
@@ Property / Cites Publication @@
+Walkey AJ, et al, Chest (2014), cited as Ref 34 in DOI: 10.1007/s11886-020-01293-2
+Normal rank
@@ Property / Cites Publication @@
+Traebert M, et al, Eur J Pharmacol (2004), cited as Ref 35 in DOI: 10.1007/s11886-020-01293-2
+Normal rank
@@ Property / has part @@
+Section 1: Introduction (from DOI: 10.1007/s11886-020-01293-2)
+Normal rank
@@ Property / has part @@
+Section 2: SARS-CoV-2 Biology and Clinical Implications (from DOI: 10.1007/s11886-020-01293-2)
+Normal rank
@@ Property / has part @@
+Section 3: Cardiovascular Comorbidities and COVID-19 Outcomes (from DOI: 10.1007/s11886-020-01293-2)
+Normal rank
@@ Property / has part @@
+Section 3.1: Cardiac Complications of COVID-19 (from DOI: 10.1007/s11886-020-01293-2)
+Normal rank
@@ Property / has part @@
+Section 3.1.1: Myocardial Injury and Heart Failure (from DOI: 10.1007/s11886-020-01293-2)
+Normal rank
@@ Property / has part @@
+Section 3.1.2: Arrhythmia (from DOI: 10.1007/s11886-020-01293-2)
+Normal rank
@@ Property / has part @@
+Section 4: Conclusion (from DOI: 10.1007/s11886-020-01293-2)
+Normal rank
@@ Property / has part @@
+Conflict of Interest (from DOI: 10.1007/s11886-020-01293-2)
+Normal rank
@@ Property / has part @@
+References (from DOI: 10.1007/s11886-020-01293-2)
@@ Property / has part: References (from DOI: 10.1007/s11886-020-01293-2) / rank @@
+Normal rank

Difference between revisions of "Cardiovascular Risks in Patients with COVID-19: Potential Mechanisms and Areas of Uncertainty (DOI: 10.1007/s11886-020-01293-2) (Q10321)"

Latest revision as of 15:53, 23 June 2020

Statements

Sitelinks

⧼wikibase-sitelinks-sliswiki⧽(1 entry)

Navigation menu

Personal tools

Namespaces

Variants

Views

More

Search

Navigation

Tools

In other languages